|
1
|
Weismann B, Rapport MM, Linker A and Meyer
K: Isolation of the aldobionic acid of umbilical cord hyaluronic
acid. J Biol Chem. 205:205–221. 1953.PubMed/NCBI
|
|
2
|
Toole BP: Hyaluronan: from extracellular
glue to pericellular cue. Nat Rev Cancer. 4:528–539. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Knudson CB and Knudson W:
Hyaluronan-binding proteins in development, tissue homeostasis, and
disease. FASEB J. 7:1233–1241. 1993.PubMed/NCBI
|
|
4
|
Auvinen P, Tammi R, Parkkinen J, et al:
Hyaluronan in peritumoral stroma and malignant cells associates
with breast cancer spreading and predicts survival. Am J Pathol.
156:529–536. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Itano N and Kimata K: Altered hyaluronan
biosynthesis in cancer progression. Semin Cancer Biol. 18:268–274.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Udabage L, Brownlee GR, Waltham M, et al:
Antisense-mediated suppression of hyaluronan synthase 2 inhibits
the tumorigenesis and progression of breast cancer. Cancer Res.
65:6139–6150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Udabage L, Brownlee GR, Nilsson SK and
Brown TJ: The over-expression of HAS2, Hyal-2 and CD44 is
implicated in the invasiveness of breast cancer. Exp Cell Res.
310:205–217. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Li L, Brown TJ and Heldin P:
Silencing of hyaluronan synthase 2 suppresses the malignant
phenotype of invasive breast cancer cells. Int J Cancer.
120:2557–2567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakamura T, Funahashi M, Takagaki K,
Munakata H, Tanaka K, Saito Y and Endo M: Effect of
4-methylumbelliferone on cell-free synthesis of hyaluronic acid.
Biochem Mol Biol Int. 43:263–268. 1997.PubMed/NCBI
|
|
10
|
Kakizaki I, Kojima K, Takagaki K, et al: A
novel mechanism for the inhibition of hyaluronan biosynthesis by
4-Methylumbelliferone. J Biol Chem. 279:33281–33289. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kultti A, Pasonen-Seppänen S, Jauhiainen
M, et al: 4-Methylumbelliferone inhibits hyaluronan synthesis by
depletion of cellular UDP-glucuronic acid and downregulation of
hyaluronan synthase 2 and 3. Exp Cell Res. 315:1914–1923. 2009.
View Article : Google Scholar
|
|
12
|
Lokeshwar VB, Lopez LE, Munoz D, et al:
Antitumor activity of hyaluronic acid synthesis inhibitor
4-methylumbelliferone in prostate cancer cells. Cancer Res.
70:2613–2623. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshihara S, Kon A, Kudo D, et al: A
hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits
liver metastasis of melanoma cells. FEBS Lett. 579:2722–2726. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arai E, Nishida Y, Wasa J, et al:
Inhibition of hyaluronan retention by 4-methylumbelliferone
suppresses osteosarcoma cells in vitro and lung metastasis in vivo.
Brit J Cancer. 105:1839–1849. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Urakawa H, Nishida Y, Wasa J, et al:
Inhibition of hyaluronan synthesis in breast cancer cells by
4-methylumbelliferone suppresses tumorigenicity in vitro and
metastatic lesions of bone in vivo. Int J Cancer. 130:454–466.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liotta LA, Mandler R, Murano G, et al:
Tumor cell autocrine motility factor. Proc Natl Acad Sci USA.
83:3302–3306. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shintani Y, Maeda M, Chaika N, Johnson KR
and Wheelock MJ: Collagen I promotes epithelial-to-mesenchymal
transition in lung cancer cells via transforming growth factor-beta
signaling. Am J Respir Cell Mol Biol. 38:95–104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zoltan-Jones A, Huang L, Ghatak S and
Toole BP: Elevated hyaluronan production induces mesenchymal and
transformed properties in epithelial cells. J Biol Chem.
278:45801–45810. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metast Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Benjamin SA, Lee AC and Saunders WJ:
Classification and behavior of canine mammary epithelial neoplasms
based on life-span observations in beagles. Vet Pathol. 36:423–436.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Klopfleisch R, von Euler H, Sarli G, Pinho
SS, Gärtner F and Gruber AD: Molecular carcinogenesis of canine
mammary tumors: News from an old disease. Vet Pathol. 48:98–116.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Uva P, Aurisicchio L, Watters J, et al:
Comparative expression pathways analysis of human and canine
mammary tumors. BMC Genomics. 10:1352009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meuten DJ: Tumors in Domestic Animals.
Meuten DJ: Iowa State Press; pp. 575–606. 2002
|
|
25
|
Saito T, Kawana H, Azuma K, Toyoda A,
Kitagawa M and Harigaya K: Fragmented hyaluronan is an autocrine
chemo-kinetic motility factor supported by the HAS2-HYAL2/CD44
system on the plasma membrane. Int J Oncol. 39:1311–1320.
2011.PubMed/NCBI
|
|
26
|
Toyoda A, Yokota A, Saito T, et al:
Overexpression of human ortholog of mammalian enabled (hMena) is
associated with the expression of mutant p53 protein in human
breast cancers. Int J Oncol. 38:89–96. 2011.PubMed/NCBI
|
|
27
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xia W, Spector S, Hardly L, Zhao S, Saluk
A, Alemane L and Spector NL: Tumor selective G2/M cell cycle arrest
and apoptosis of epithelial and hematological malignancies by
BBL22, a benzazepine. Proc Natl Acad Sci USA. 97:7494–7499. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu M, Pollock RE and Nicolson GL:
Purification and characterization of human lung fibroblast
motility-stimulating factor for human soft tissue sarcoma cells:
identification as an NH2-terminal fragments of human fibronectin.
Cancer Res. 57:3577–3584. 1997.
|
|
30
|
Anttila MA, Tammi RH, Tammi MI, Syrjänen
KJ, Saarikoski SV and Kosma VM: High levels of stromal hyaluronan
predict poor disease outcome in epithelial ovarian cancer. Cancer
Res. 60:150–155. 2000.PubMed/NCBI
|
|
31
|
Lipponen P, Aaltomaa S, Tammi R, Tammi M,
Agren U and Kosma VM: High stromal hyaluronan level is associated
with poor differentiation and metastasis in prostate cancer. Eur J
Cancer. 37:849–856. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Posey JT, Soloway MS, Ekici S, Sofer M,
Civantos F, Duncan RC and Lokeshwar VB: Evaluation of prognostic
potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate
cancer. Cancer Res. 63:2638–2644. 2003.PubMed/NCBI
|
|
33
|
Bourguignon LY, Zhu H, Chu A, Iida N,
Zhang L and Hung MC: Interaction between the adhesion receptor,
CD44, and the oncogene product, p185HER2, promotes human ovarian
tumor cell activation. J Biol Chem. 272:27913–27918. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ouhit A, Abd Elmageed ZY, Abdraboh ME,
Lioe TF and Raj MH: In vivo evidence for the role of CD44s in
promoting breast cancer metastasis to the liver. Am J Pathol.
171:2033–2039. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Paltian V, Alldinger S, Baumgärtner W and
Wohlsein P: Expression of CD44 in canine mammary tumours. J Comp
Path. 141:237–247. 2009. View Article : Google Scholar : PubMed/NCBI
|
